Followers | 65 |
Posts | 7180 |
Boards Moderated | 0 |
Alias Born | 03/06/2016 |
Thursday, April 13, 2017 1:39:12 PM
What the FDA should do is not to consider INSPIRE successful UNTIL EACH APPROVED SITE completes at least one procedure.
No point approving something with only a handful of hospitals every attempting the procedure.
The second arm should be an independent study that's runs concurrent with INSPIRE. Two results and two approvals. To say this will not increase the timeline is genuinely misleading. Mark is the only person who believes this. I bet he doesn't even truly believe it.
This company had so much potential. Too bad there were so many missteps.
Even with 4 more conversions we will be lucky to see $4
Good luck to anybody still invested here.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM